Patient Access to PCSK9 Inhibitors
When health plans boost their bottom line by blocking access to medicine, it's heart patients who pay the price.
Dr. Dharmesh Patel Discusses Cardio Health
Dr. Dharmesh Patel talks about how the use of burdensome utilization management practices such as prior authorization keep potentially life-saving therapies from patients.
Understanding Prior Authorization
What began as a safeguard against unnecessary drug spending has become a significant barrier to patient access.
Accessing Breakthrough Cholesterol Treatments
Health plans deny up to 3 out of every 4 patients who have been prescribed a PCSK9 inhibitor by their doctor.
PCSK9 Inhibitors: Access Barriers Affect Real People
This video, filmed at a town hall hosted by the American Society for Preventive Cardiology (ASPC) in Washington, D.C., highlights not only patient testimonials, but also the concerted effort by health care providers to overcome these remarkable denial rates.